Even
though Israel has no restrictions on embryonic stem cell research the Israeli
company has decided to invest only in adult stem cells for practical reasons
in its mission to provide treatment for neurological disorders such as Lou
Gehrig's disease and Parkinson's.
Reuters
Excerpt:
Ironically, in the Jewish state of Israel embryonic stem cell research
is less controversial, noted BrainStorm's ultra-orthodox president, Chaim
Lebovits.
Still, the company said it has decided to concentrate on
adult stem cells because they are also easier to control than embryonic cells,
which can give rise to tumours.